Investment Centers of America Inc. cut its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 20.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,756 shares of the pharmacy operator’s stock after selling 2,023 shares during the quarter. Investment Centers of America Inc.’s holdings in Walgreens Boots Alliance were worth $597,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Commonwealth Bank of Australia grew its stake in Walgreens Boots Alliance by 139.5% in the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after purchasing an additional 26,893 shares in the last quarter. Andra AP fonden grew its stake in Walgreens Boots Alliance by 6.9% in the third quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock valued at $4,811,000 after purchasing an additional 4,000 shares in the last quarter. IBM Retirement Fund grew its stake in Walgreens Boots Alliance by 88.1% in the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after purchasing an additional 10,729 shares in the last quarter. Schwab Charles Investment Management Inc. grew its stake in Walgreens Boots Alliance by 5.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after purchasing an additional 154,995 shares in the last quarter. Finally, Birinyi Associates Inc. grew its stake in Walgreens Boots Alliance by 9.0% in the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after purchasing an additional 750 shares in the last quarter. Institutional investors and hedge funds own 61.18% of the company’s stock.
WBA has been the subject of a number of analyst reports. Jefferies Group restated a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Monday, October 2nd. Needham & Company LLC restated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. Mizuho set a $94.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Tuesday, October 24th. Royal Bank of Canada restated a “buy” rating and issued a $88.00 price target on shares of Walgreens Boots Alliance in a research note on Wednesday, October 25th. Finally, Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $86.05.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.27 by $0.01. The company had revenue of $30.74 billion during the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business’s revenue was up 7.9% on a year-over-year basis. During the same period last year, the firm posted $1.10 earnings per share. sell-side analysts anticipate that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Investors of record on Monday, November 13th were issued a dividend of $0.40 per share. The ex-dividend date of this dividend was Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.19%. Walgreens Boots Alliance’s payout ratio is currently 44.20%.
Walgreens Boots Alliance announced that its board has authorized a stock buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to purchase shares of its stock through open market purchases. Shares buyback programs are generally an indication that the company’s management believes its stock is undervalued.
In other news, Director John Anthony Lederer purchased 20,000 shares of the company’s stock in a transaction that occurred on Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 14.80% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This article was first posted by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.chaffeybreeze.com/2018/01/06/investment-centers-of-america-inc-decreases-position-in-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.